Literature DB >> 11869367

Control or persistence of hepatitis B virus: the critical role of initial host-virus interactions.

George Jm Webster1, Antonio Bertoletti.   

Abstract

Following infection with hepatitis B virus (HBV), the period before symptomatic disease is now recognized as a time of dynamic interaction between virus and host. Recent work has shown that this period is the phase of infection during which maximal changes in virus replication and the activation of critical components of the immune system occurs. This suggests that the different outcomes following exposure might be determined during the early phase of infection, before the onset of clinical disease. The hypothesis that small differences in the dynamic relationship between host and virus, such as in the kinetics of HBV replication, may influence the final outcome of infection, will be discussed.

Entities:  

Mesh:

Year:  2002        PMID: 11869367     DOI: 10.1046/j.1440-1711.2002.01060.x

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  4 in total

1.  An intermediate dose of LCMV clone 13 causes prolonged morbidity that is maintained by CD4+ T cells.

Authors:  Andrew Stamm; Laura Valentine; Rashaun Potts; Mary Premenko-Lanier
Journal:  Virology       Date:  2012-02-04       Impact factor: 3.616

2.  Unique hepatitis B virus subgenotype in a primitive tribal community in eastern India.

Authors:  Sumantra Ghosh; Priyanka Banerjee; Arindam RoyChoudhury; Sumanta Sarkar; Alip Ghosh; Amal Santra; Soma Banerjee; Kausik Das; Bhagirathi Dwibedi; Shantanu K Kar; Vikas Gangadhar Rao; Jyothi T Bhat; Neeru Singh; Abhijit Chowdhury; Simanti Datta
Journal:  J Clin Microbiol       Date:  2010-09-15       Impact factor: 5.948

3.  Hepatitis B core antigen upregulates B7-H1 on dendritic cells by activating the AKT/ERK/P38 pathway: a possible mechanism of hepatitis B virus persistence.

Authors:  Man Li; Zhen-Hua Zhou; Xue-Hua Sun; Xin Zhang; Xiao-Jun Zhu; Shu-Gen Jin; Ya-Ting Gao; Yun Jiang; Yue-Qiu Gao
Journal:  Lab Invest       Date:  2016-09-12       Impact factor: 5.662

4.  Modelling the Impact of Cell-To-Cell Transmission in Hepatitis B Virus.

Authors:  Ashish Goyal; John M Murray
Journal:  PLoS One       Date:  2016-08-25       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.